Pharmaceutical company
Appears in 1 story · Last updated Oct 29, 2026
Developer and U.S. commercializer of WELTRUZA
Teva's WELTRUZA is the first once-monthly subcutaneous olanzapine injection for schizophrenia. Patients skip the loading doses, oral supplementation and post-injection observation that shaped use of the older injectable form.
Updated Oct 29
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
